SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001640455-21-000079
Filing Date
2021-04-26
Accepted
2021-04-26 16:42:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A jnce04262021defa14a.htm DEFA14A 16260
2 jnce_2021xnotice11.jpg GRAPHIC 532108
3 jnce_2021xnotice21.jpg GRAPHIC 327822
  Complete submission text file 0001640455-21-000079.txt   1201160
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37998 | Film No.: 21854440
SIC: 2836 Biological Products, (No Diagnostic Substances)